Table 2.

Summary of model performance on all days and unstable days.

All days
Unstable days
Test set
NephrocastReference SCrP-valueNephrocastReference SCrP-value
MAE, median (IQR), mg/dL0.09 (0.085, 0.09)0.13 (0.131, 0.135)<.010.20 (0.197, 0.203)0.54 (0.532, 0.548)<.01
RMSE, median (IQR), mg/dL0.15 (0.146,0.152)0.25 (0.245, 0.253)<.010.31 (0.307, 0.327)0.67 (0.663, 0.694)<.01
Temporal validation
MAE, mg/dL0.080.13N/A0.190.54N/A
RMSE, mg/dL0.140.25N/A0.310.66N/A
Prospective validation
MAE, mg/dL0.090.13N/A0.180.50N/A
RMSE, mg/dL0.140.23N/A0.280.60N/A
All days
Unstable days
Test set
NephrocastReference SCrP-valueNephrocastReference SCrP-value
MAE, median (IQR), mg/dL0.09 (0.085, 0.09)0.13 (0.131, 0.135)<.010.20 (0.197, 0.203)0.54 (0.532, 0.548)<.01
RMSE, median (IQR), mg/dL0.15 (0.146,0.152)0.25 (0.245, 0.253)<.010.31 (0.307, 0.327)0.67 (0.663, 0.694)<.01
Temporal validation
MAE, mg/dL0.080.13N/A0.190.54N/A
RMSE, mg/dL0.140.25N/A0.310.66N/A
Prospective validation
MAE, mg/dL0.090.13N/A0.180.50N/A
RMSE, mg/dL0.140.23N/A0.280.60N/A

Reference SCr was defined as the measured SCr on the day of making the prediction. Predicted SCr was defined as the predicted SCr by our model for the next patient-day. Measured SCr was defined as the laboratory measured SCr on the next patient-day. Model error was defined as the difference between predicted SCr and measured SCr, which was compared against the difference between reference SCr and measured SCr. Error was summarized using MAE and RMSE. Unstable patient-days were defined as those in which there was a change of 30% or 0.3 mg/dL or more in SCr concentration between the reference SCr and the measured SCr on the following patient-day.

Abbreviations: IQR = interquartile range; MAE = mean absolute error; RMSE = root mean squared error; SCr = serum creatinine.

Table 2.

Summary of model performance on all days and unstable days.

All days
Unstable days
Test set
NephrocastReference SCrP-valueNephrocastReference SCrP-value
MAE, median (IQR), mg/dL0.09 (0.085, 0.09)0.13 (0.131, 0.135)<.010.20 (0.197, 0.203)0.54 (0.532, 0.548)<.01
RMSE, median (IQR), mg/dL0.15 (0.146,0.152)0.25 (0.245, 0.253)<.010.31 (0.307, 0.327)0.67 (0.663, 0.694)<.01
Temporal validation
MAE, mg/dL0.080.13N/A0.190.54N/A
RMSE, mg/dL0.140.25N/A0.310.66N/A
Prospective validation
MAE, mg/dL0.090.13N/A0.180.50N/A
RMSE, mg/dL0.140.23N/A0.280.60N/A
All days
Unstable days
Test set
NephrocastReference SCrP-valueNephrocastReference SCrP-value
MAE, median (IQR), mg/dL0.09 (0.085, 0.09)0.13 (0.131, 0.135)<.010.20 (0.197, 0.203)0.54 (0.532, 0.548)<.01
RMSE, median (IQR), mg/dL0.15 (0.146,0.152)0.25 (0.245, 0.253)<.010.31 (0.307, 0.327)0.67 (0.663, 0.694)<.01
Temporal validation
MAE, mg/dL0.080.13N/A0.190.54N/A
RMSE, mg/dL0.140.25N/A0.310.66N/A
Prospective validation
MAE, mg/dL0.090.13N/A0.180.50N/A
RMSE, mg/dL0.140.23N/A0.280.60N/A

Reference SCr was defined as the measured SCr on the day of making the prediction. Predicted SCr was defined as the predicted SCr by our model for the next patient-day. Measured SCr was defined as the laboratory measured SCr on the next patient-day. Model error was defined as the difference between predicted SCr and measured SCr, which was compared against the difference between reference SCr and measured SCr. Error was summarized using MAE and RMSE. Unstable patient-days were defined as those in which there was a change of 30% or 0.3 mg/dL or more in SCr concentration between the reference SCr and the measured SCr on the following patient-day.

Abbreviations: IQR = interquartile range; MAE = mean absolute error; RMSE = root mean squared error; SCr = serum creatinine.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close